165 related articles for article (PubMed ID: 34037984)
21. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
22. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.
Chung SH; Heimbürger O; Stenvinkel P; Wang T; Lindholm B
Perit Dial Int; 2003; 23(2):174-83. PubMed ID: 12713086
[TBL] [Abstract][Full Text] [Related]
23. Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.
Roumeliotis S; Dounousi E; Salmas M; Eleftheriadis T; Liakopoulos V
Biomolecules; 2020 May; 10(5):. PubMed ID: 32423139
[TBL] [Abstract][Full Text] [Related]
24. Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients.
Hur SM; Ju HY; Park MY; Choi SJ; Kim JK; Hwang SD
Korean J Intern Med; 2014 Jul; 29(4):489-97. PubMed ID: 25045297
[TBL] [Abstract][Full Text] [Related]
25. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress.
Sundl I; Roob JM; Meinitzer A; Tiran B; Khoschsorur G; Haditsch B; Holzer H; Winklhofer-Roob BM
Perit Dial Int; 2009; 29(1):89-101. PubMed ID: 19164258
[TBL] [Abstract][Full Text] [Related]
27. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.
Mitrogianni Z; Barbouti A; Galaris D; Siamopoulos KC
Nephron Clin Pract; 2009; 113(3):c234-40. PubMed ID: 19690441
[TBL] [Abstract][Full Text] [Related]
28. Study of Protein Oxidative Stress, Antioxidant Vitamins and Inflammation in Patients Undergoing either Hemodialysis or Peritoneal Dialysis.
Marques de Mattos A; Afonso Jordão A; Abrão Cardeal da Costa J; Garcia Chiarello P
Int J Vitam Nutr Res; 2014; 84(5-6):261-8. PubMed ID: 26255547
[TBL] [Abstract][Full Text] [Related]
29. The 24-Month Changes in Body Fat Mass and Adipokines in Patients Starting Peritoneal Dialysis.
Choi SJ; Park MY; Kim JK; Hwang SD
Perit Dial Int; 2017; 37(3):290-297. PubMed ID: 28096439
[TBL] [Abstract][Full Text] [Related]
30. Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study.
Levin A; Nair D; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Stenvinkel P; Bruchfeld A; Ungerstedt JS
Nephron; 2018; 140(4):249-256. PubMed ID: 30253414
[TBL] [Abstract][Full Text] [Related]
31. Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients.
Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
Perit Dial Int; 2015; 35(1):35-42. PubMed ID: 24711638
[TBL] [Abstract][Full Text] [Related]
32. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study.
Nascimento MM; Suliman ME; Silva M; Chinaglia T; Marchioro J; Hayashi SY; Riella MC; Lindholm B; Anderstam B
Perit Dial Int; 2010; 30(3):336-42. PubMed ID: 20190028
[TBL] [Abstract][Full Text] [Related]
33. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
34. Dialysis-related systemic microinflammation is associated with specific genomic patterns.
Zaza G; Pontrelli P; Pertosa G; Granata S; Rossini M; Porreca S; Staal FJ; Gesualdo L; Grandaliano G; Schena FP
Nephrol Dial Transplant; 2008 May; 23(5):1673-81. PubMed ID: 18048420
[TBL] [Abstract][Full Text] [Related]
35. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
[TBL] [Abstract][Full Text] [Related]
36. Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.
Xu H; Cabezas-Rodriguez I; Qureshi AR; Heimburger O; Barany P; Snaedal S; Anderstam B; Helin AC; Carrero JJ; Stenvinkel P; Lindholm B
Perit Dial Int; 2015; 35(4):460-70. PubMed ID: 24584606
[TBL] [Abstract][Full Text] [Related]
37. Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
Rroji M; Spahia N; Seferi S; Barbullushi M; Spasovski G
Ther Apher Dial; 2017 Oct; 21(5):451-458. PubMed ID: 28714271
[TBL] [Abstract][Full Text] [Related]
38. Cognitive Changes in Peritoneal Dialysis Patients: A Multicenter Prospective Cohort Study.
Zhang YH; Yang ZK; Wang JW; Xiong ZY; Liao JL; Hao L; Liu GL; Ren YP; Wang Q; Duan LP; Zheng ZX; Dong J
Am J Kidney Dis; 2018 Nov; 72(5):691-700. PubMed ID: 30007504
[TBL] [Abstract][Full Text] [Related]
39. Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patients.
Fu S; Chen J; Liu B; Liang P; Zeng Y; Feng M; Xu Z; Zheng G; Yang S; Xu A; Tang Y
BMC Nephrol; 2020 Jun; 21(1):237. PubMed ID: 32576274
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
Rodrigues AS; Almeida M; Fonseca I; Martins M; Carvalho MJ; Silva F; Correia C; Santos MJ; Cabrita A
Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
